Find a Trial
Trial Results
5 protocol(s) meet the specified criteria
CTO-BTCRC-LUN18-363OPEN TO ACCRUAL
CTO-EA2174OPEN TO ACCRUAL
A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
CTO-LUNGMAPOPEN TO ACCRUAL
A MASTER PROTOCOL TO EVALUATE BIOMARKER-DRIVEN THERAPIES AND IMMUNOTHERAPIES IN PREVIOUSLY-TREATED NON-SMALL CELL LUNG CANCER (Lung-MAP Screening Study)
CTO-NP-G2-044-P2-01OPEN TO ACCRUAL
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
ESO17-325OPEN TO ACCRUAL
A Phase II Study Evaluating Safety and Efficacy of Niraparib in Patients with Previously Treated Homologous Recombination (HR) Defective or Loss of Heterozygosity (LOH) high Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma